HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Summary

Zoledronic acid was initially used for bone metastases in various malignancies. However, it is unknown whether hepatic arterial infusion chemotherapy combined with zoledronic acid can improve overall survival of unresectable hepatocellular carcinoma.

Timeline

Start

2023-05-10

Primary completion

2024-12-01

Completion

2025-06-01

Drugs

Indications